HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2062211Generated: October 25, 2026
Triethylamine → (R)-1-(4-(6-bromo-2-(2-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)-2-hydroxy-4-methylpentan-1-one
https://huagongshe.com/reaction/2062211
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | (R)-2-hydroxy-4-methyl-1-(piperazin-1-yl)pentan-1-one | HCID 59216548 | — |
| Reactant | 2-(6-Bromo-4-chloroquinazolin-2-yl)phenol | HCID 136121500 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | (R)-1-(4-(6-bromo-2-(2-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)-2-hydroxy-4-methylpentan-1-one | HCID 136121577 | 84% |
Reaction Steps
To a solution of 2-(6-bromo-4-chloroquinazolin-2-yl)phenol (228 mg, 0.68 mmol), triethylamine (129 μL, 0.92 mmol), and CH2Cl2 (6 mL) was added (R)-2-hydroxy-4-methyl-1-(piperazin-1-yl)pentan-1-one (185 mg, 0.92 mmol) dissolved in CH2Cl2 (3 mL). The flask was flushed with N2 and stirred for 3 hours. The reaction mixture was then transferred into a separatory funnel with CH2Cl2, and the organic phase was washed with H2O (2×), dried over Na2SO4, and concentrated. Purification via silica gel chromatography using 0 to 20% EtOAc and CH2Cl2:hexanes (1:1) gave (R)-1-(4-(6-bromo-2-(2-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)-2-hydroxy-4-methylpentan-1-one (285 mg, 84%). LC/MS: m/z 500.30 (M+H)+ at 3.29 min (10%-99% CH3CN (0.035% TFA)/H2O (0.05% TFA)).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08283354B2 |
|---|
| Source dataset | uspto-grants-2012_10 |
|---|
| ORD ID | ord-fd2b1b47260b4c11a2ab9e193a994c5c |
|---|
| Source note | uspto-grants-2012_10 |
|---|